$105.50
1.96[1.89%]
At close: Apr 25
$105.50
0[0.00%]
After Hours: 4:55PM EDT
Cardinal Health
(NYSE:CAH)Cardinal Health Stock (NYSE:CAH), Analyst Ratings, Price Targets, Predictions
Cardinal Health Inc has a consensus price target of $87.23, established from looking at the 55 latest analyst ratings. The last 3 analyst ratings were released from Leerink Partners, Argus Research, and UBS on February 26, 2024, February 9, 2024, and February 5, 2024. With an average price target of $83.33 between Leerink Partners, Argus Research, and UBS, there's an implied -21.01% downside for Cardinal Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Leerink Partners
Argus Research
UBS
Barclays
Wells Fargo
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cardinal Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/26/2024 | CAH | Buy Now | Cardinal Health | $105.50 | 18.48% | Leerink Partners | Michael Cherny | → $125 | Initiates | → Outperform | Get Alert |
| 02/09/2024 | CAH | Buy Now | Cardinal Health | $105.50 | — | Argus Research | David Toung | — | Upgrade | Hold → Buy | Get Alert |
| 02/05/2024 | CAH | Buy Now | Cardinal Health | $105.50 | 18.48% | UBS | Kevin Caliendo | $122 → $125 | Maintains | Buy | Get Alert |
| 01/29/2024 | CAH | Buy Now | Cardinal Health | $105.50 | 15.64% | UBS | Kevin Caliendo | $114 → $122 | Maintains | Buy | Get Alert |
| 01/03/2024 | CAH | Buy Now | Cardinal Health | $105.50 | 10.9% | Barclays | Stephanie Davis | → $117 | Initiates | → Overweight | Get Alert |
| 12/14/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -9% | Wells Fargo | Stephen Baxter | → $96 | Initiates | → Underweight | Get Alert |
| 11/17/2023 | CAH | Buy Now | Cardinal Health | $105.50 | 6.16% | JP Morgan | Lisa Gill | $101 → $112 | Maintains | Neutral | Get Alert |
| 11/06/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -1.42% | Mizuho | Ann Hynes | $95 → $104 | Maintains | Neutral | Get Alert |
| 08/16/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -14.69% | TD Cowen | Charles Rhyee | $88 → $90 | Maintains | Market Perform | Get Alert |
| 08/16/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -4.27% | JP Morgan | Lisa Gill | $93 → $101 | Maintains | Neutral | Get Alert |
| 08/16/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -5.21% | Morgan Stanley | Erin Wright | $92 → $100 | Maintains | Overweight | Get Alert |
| 08/16/2023 | CAH | Buy Now | Cardinal Health | $105.50 | 2.37% | Baird | Eric Coldwell | $107 → $108 | Maintains | Outperform | Get Alert |
| 08/16/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -9% | Mizuho | Ann Hynes | $94 → $96 | Maintains | Neutral | Get Alert |
| 07/11/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -10.9% | Mizuho | Ann Hynes | $85 → $94 | Maintains | Neutral | Get Alert |
| 07/10/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -5.21% | Evercore ISI Group | Elizabeth Anderson | → $100 | Downgrade | Outperform → In-Line | Get Alert |
| 06/12/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -14.69% | Citigroup | Daniel Grosslight | $88 → $90 | Maintains | Neutral | Get Alert |
| 06/12/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -19.43% | Barclays | Steven Valiquette | $80 → $85 | Maintains | Equal-Weight | Get Alert |
| 06/12/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -5.21% | Credit Suisse | Jonathan Yong | $90 → $100 | Maintains | Neutral | Get Alert |
| 06/12/2023 | CAH | Buy Now | Cardinal Health | $105.50 | -8.06% | UBS | Kevin Caliendo | $93 → $97 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cardinal Health (CAH)?
The latest price target for Cardinal Health (NYSE: CAH) was reported by Leerink Partners on February 26, 2024. The analyst firm set a price target for $125.00 expecting CAH to rise to within 12 months (a possible 18.48% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cardinal Health (CAH)?
The latest analyst rating for Cardinal Health (NYSE: CAH) was provided by Leerink Partners, and Cardinal Health initiated their outperform rating.
When was the last upgrade for Cardinal Health (CAH)?
The last upgrade for Cardinal Health Inc happened on February 9, 2024 when Argus Research raised their price target to N/A. Argus Research previously had a hold for Cardinal Health Inc.
When was the last downgrade for Cardinal Health (CAH)?
The last downgrade for Cardinal Health Inc happened on July 10, 2023 when Evercore ISI Group changed their price target from N/A to $100 for Cardinal Health Inc.
When is the next analyst rating going to be posted or updated for Cardinal Health (CAH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardinal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardinal Health was filed on February 26, 2024 so you should expect the next rating to be made available sometime around February 26, 2025.
Is the Analyst Rating Cardinal Health (CAH) correct?
While ratings are subjective and will change, the latest Cardinal Health (CAH) rating was a initiated with a price target of $0.00 to $125.00. The current price Cardinal Health (CAH) is trading at is $105.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.